Related Experiment Video
Updated: Jun 30, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease
Roddy McDowell1, Jennifer S Li, Daniel Kelly Benjamin
1Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
Insights
Enzyme replacement therapy for infantile Pompe disease is linked to a high incidence of arrhythmias in children. Further research is needed to identify specific risk factors and guide screening protocols.
Area of Science:
- Pediatric Cardiology
- Genetics
- Metabolic Disorders
Background:
- Enzyme replacement therapy (ERT) improves outcomes in infantile Pompe disease.
- Cardiac abnormalities, including ectopy, have been observed in these patients.
Purpose of the Study:
- To determine the prevalence and types of arrhythmias in infants with Pompe disease receiving ERT.
- To investigate potential associations between arrhythmias and cardiac parameters.
Main Methods:
- Retrospective review of data from 38 children with infantile Pompe disease in clinical trials.
- Analysis of electrocardiograms and echocardiograms for QT interval, ejection fraction, and left ventricular mass.
- Identification and characterization of arrhythmias from various monitoring sources.
Main Results:
- Arrhythmias occurred in 18% (7 of 38) of children.
- No significant differences in cardiac parameters were found between children with and without arrhythmias.
- Two children with severe arrhythmias had high baseline cardiac measurements and experienced events during metabolic stress.
Conclusions:
- A high incidence of arrhythmias was observed in this cohort.
- The relationship between ERT, arrhythmias, myocardial fibrosis, and survival requires further investigation.
- Continued vigilance and screening for arrhythmias in children receiving ERT are recommended.
Purpose:
Enzyme replacement therapy in infants with Pompe disease prolongs survival, decreases cardiomegaly, and improves muscle function. Because ectopy has been previously described in these patients, we sought to determine the prevalence and types of arrhythmias.
Methods:
Thirty-eight children with infantile Pompe disease received enzyme replacement therapy in two open-label, multicenter, international, clinical trials. Data were reviewed on a retrospective basis. The corrected QT interval, ejection fraction, and indexed left ventricular mass were measured on a scheduled basis from electrocardiograms and echocardiograms. Arrhythmias were identified and characterized from electrocardiograms, ambulatory electrocardiograms, and point-of-care monitoring. Electrocardiogram and echocardiogram measurements were compared in children with and without arrhythmias.
Results:
Seven children (18%) experienced arrhythmias. The QT interval, ejection fraction, indexed left ventricular mass, and rate of reduction of indexed left ventricular mass were not statistically different in those seven versus the other 31 children. Two children with life-threatening arrhythmias had among the highest combined baseline maximum indexed left ventricular mass and QT interval. Their arrhythmias occurred during severe metabolic stress from noncardiac illness.
Conclusions:
There was a high incidence of arrhythmias in our cohort. The relationship of arrhythmias with enzyme replacement therapy, myocardial fibrosis, or simply longer survival is unknown. Therefore, further characterization of specific arrhythmia risk factors and continued vigilance regarding screening for arrhythmias in children receiving enzyme replacement therapy is warranted.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Dysrhythmias III: Characteristics of Dysrhythmias
